Advertisement
ALHC vs HUM
Which Stock Would AI Choose? Alignment Healthcare (ALHC) vs. Humana (HUM) Stock Comparison
Key Takeaways
- Both ALHC and HUM focus on Medicare Advantage (MA) plans in the healthcare sector, benefiting from recent CMS reimbursement hikes.
- ALHC, with a $4.3 billion market cap, has turned profitable amid revenue growth to $3.95 billion TTM (trailing twelve months), driving recent stock momentum.
- HUM, a $26 billion market cap giant, reports $130 billion TTM revenue and a trailing P/E (price-to-earnings) ratio of 22, reflecting established profitability.
- ALHC YTD gains stand at 7%, with a beta of 1.20 indicating higher volatility, while HUM shows 15% YTD and lower beta of 0.44 for stability.
- Recent market activity saw ALHC surge over 16% on MA news, outpacing HUM's 9% rise post-earnings outlook update.
Introduction
This stock comparison pits ALHC against HUM, two players in the competitive Medicare Advantage space amid shifting reimbursement rates and healthcare sector dynamics. Investors tracking healthcare stocks may find value here, as both companies navigate regulatory changes, membership growth, and operational efficiencies. Traders focused on relative performance will note contrasts in scale, volatility, and recent catalysts. With broader market positioning influenced by policy updates, this analysis highlights key metrics and trends for informed decision-making in the current environment.
ALHC Overview and Recent Performance
Alignment Healthcare (ALHC) provides Medicare Advantage health plans leveraging technology for personalized senior care. In recent weeks, the stock has rallied significantly, surging over 16% following positive CMS (Centers for Medicare & Medicaid Services) reimbursement announcements for 2026 MA rates. Trading around $21, ALHC boasts a market cap of $4.3 billion and YTD gains of 7%. Key drivers include turning profitable, robust revenue expansion to $3.95 billion TTM, and analyst upgrades like Wolfe Research's Outperform rating with a $24 target. Sentiment has shifted positively on cash generation and membership growth, though high beta of 1.20 signals volatility tied to policy and execution risks.
HUM Overview and Recent Performance
Humana (HUM) is a major health insurer offering MA plans, commercial coverage, and services via its CenterWell brand. Recent market activity featured a 9.6% stock climb after raising its 2025 EPS outlook and expanding whole-person care initiatives. Priced near $217 with a $26 billion market cap, HUM has delivered 15% YTD returns amid broader sector tailwinds from MA rate hikes. Influences include partnerships like with Mark Cuban Cost Plus Drug Company, though rising operating costs pressure margins ahead of Q1 earnings. Stable beta of 0.44 underscores resilience, supported by $130 billion TTM revenue and EPS of $9.84.
Trending AI Robots
Tickeron's Trending AI Robots page showcases the top 25 AI trading bots out of 351 available, curated for current market conditions across stocks, ETFs, and crypto. These bots employ diverse strategies—from short-term volatility plays to long-term trend following—with impressive stats like annualized returns up to +167%, win rates ranging 48% to 88%, profit factors from 1.5 to 6.9, and average trade durations from hours to 55 days. Multi-ticker portfolios (up to 25 symbols) target themes like semiconductors, small caps, and leveraged ETFs, incorporating risk management such as corridor take-profit/stop-loss exits. Hundreds of bots trade thousands of tickers with varying styles, timeframes, and performances, making the trending section ideal for spotting high-potential signals. Explore Trending AI Robots to align automated strategies with your trading goals.
Head-to-Head Comparison
ALHC and HUM share MA exposure but differ in scale: HUM's diversified model includes primary care services, yielding massive revenue versus ALHC's tech-focused niche growth. Recent momentum favors ALHC with sharper gains on catalysts, while HUM offers steadier climbs. Risk profiles contrast via beta—ALHC 1.20 for upside volatility, HUM 0.44 for defense. Sector pressures like medical loss ratios affect both, but ALHC faces execution risks in scaling, versus HUM's cost headwinds. Market sentiment tilts toward growth for ALHC, stability for HUM, influencing trader preferences in volatile healthcare positioning.
Tickeron AI Verdict
Tickeron's AI would currently favor ALHC for its stronger trend consistency in recent weeks, bolstered by profitability milestones, Medicare catalysts, and relative outperformance versus HUM. While HUM provides scale and lower volatility, ALHC's momentum positions it probabilistically better for near-term upside in the MA landscape.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALHC is a StrongBuy and HUM is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALHC’s FA Score shows that 0 FA rating(s) are green whileHUM’s FA Score has 3 green FA rating(s).
- ALHC’s FA Score: 0 green, 5 red.
- HUM’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALHC’s TA Score shows that 5 TA indicator(s) are bullish while HUM’s TA Score has 3 bullish TA indicator(s).
- ALHC’s TA Score: 5 bullish, 6 bearish.
- HUM’s TA Score: 3 bullish, 5 bearish.
Price Growth
ALHC (@Managed Health Care) experienced а +7.58% price change this week, while HUM (@Managed Health Care) price change was -2.80% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.72%. For the same industry, the average monthly price growth was +14.43%, and the average quarterly price growth was +37.57%.
Reported Earning Dates
ALHC is expected to report earnings on Jul 30, 2026.
HUM is expected to report earnings on Jul 29, 2026.
Industries' Descriptions
@Managed Health Care (+0.72% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| ALHC | HUM | ALHC / HUM | |
| Capitalization | 4.48B | 43.1B | 10% |
| EBITDA | 66.4M | N/A | - |
| Gain YTD | 7.747 | 40.926 | 19% |
| P/E Ratio | 212.80 | 38.50 | 553% |
| Revenue | 4.26B | 137B | 3% |
| Total Cash | 726M | 22B | 3% |
| Total Debt | 330M | 14B | 2% |
HUM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 95 | |
PRICE GROWTH RATING 1..100 | 4 | |
P/E GROWTH RATING 1..100 | 8 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALHC | HUM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 77% | N/A |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 60% |
| Advances ODDS (%) | 6 days ago 81% | 9 days ago 60% |
| Declines ODDS (%) | 12 days ago 83% | 6 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 56% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JPSE | 59.42 | 0.20 | +0.34% |
| JPMorgan Divers Ret US Small Cap Eq ETF | |||
| GOEX | 75.42 | -0.09 | -0.12% |
| Global X Gold Explorers ETF | |||
| KPRO | 26.60 | -0.07 | -0.26% |
| KraneShares 100% KWEB Dfnd OutcmJan27ETF | |||
| FDVV | 60.39 | -0.20 | -0.33% |
| Fidelity High Dividend ETF | |||
| DVGR | 26.35 | -0.35 | -1.31% |
| DAC 3D Dividend Growth ETF | |||
ALHC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALHC has been loosely correlated with UNH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ALHC jumps, then UNH could also see price increases.
| Ticker / NAME | Correlation To ALHC | 1D Price Change % | ||
|---|---|---|---|---|
| ALHC | 100% | -2.65% | ||
| UNH - ALHC | 42% Loosely correlated | +1.43% | ||
| CVS - ALHC | 36% Loosely correlated | +3.03% | ||
| HUM - ALHC | 33% Poorly correlated | +0.02% | ||
| ELV - ALHC | 32% Poorly correlated | +1.63% | ||
| CLOV - ALHC | 29% Poorly correlated | +2.42% | ||
More | ||||